Addex Pharmaceuticals S.A.
Records under this name other than the patents Addex Pharmaceuticals S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Back to Addex Pharmaceuticals S.A.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,114,138 | 1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,674,106 | Alkynyl derivatives as modulators of metabotropic glutamate receptors Formerly held Term ended Ended no later than Jun 17, 2025 · From the USPTO record | Term ended | Ended no later than Jun 17, 2025 | From the USPTO record |
| US 8,883,826 | Alkynyl derivatives as modulators of metabotropic glutamate receptors Formerly held Term ended Term ended Jun 17, 2025 · From the USPTO record | Term ended | Term ended Jun 17, 2025 | From the USPTO record |
| US 8,399,493 | Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors Formerly held Lapsed on the fee record Ended Mar 19, 2025 · From the USPTO record | Lapsed on the fee record | Ended Mar 19, 2025 | From the USPTO record |
| US 8,748,621 | 1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones Formerly held Lapsed on the fee record Ended Jun 10, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jun 10, 2022 | From the USPTO record |
| US 8,722,894 | 1,3-disubstituted-4-phenyl-1H-pyridin-2-ones Formerly held Lapsed on the fee record Ended May 13, 2022 · From the USPTO record | Lapsed on the fee record | Ended May 13, 2022 | From the USPTO record |
| US 8,252,937 | 1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones Formerly held Lapsed on the fee record Ended Aug 28, 2020 · From the USPTO record | Lapsed on the fee record | Ended Aug 28, 2020 | From the USPTO record |
| US 7,205,411 | Aminopyridine derivatives as mGluR5 antagonists Formerly held Lapsed on the fee record Ended Apr 17, 2015 · From the USPTO record | Lapsed on the fee record | Ended Apr 17, 2015 | From the USPTO record |
| US 7,834,035 | Allosteric modulators of metabotropic glutamate receptors Formerly held Lapsed on the fee record Ended Nov 16, 2014 · From the USPTO record | Lapsed on the fee record | Ended Nov 16, 2014 | From the USPTO record |
| US 6,211,173 | Use of 2,3,4,5-tetrahydro-1H-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders Formerly held Lapsed on the fee record Ended Apr 3, 2013 · From the USPTO record | Lapsed on the fee record | Ended Apr 3, 2013 | From the USPTO record |